ArticlePediatric investigation2026
Pediatric spinal ependymomas: Long-term surgical outcomes in a cohort of 61 cases.
Article in Pediatric investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Spinal ependymomas are rare in the pediatric population, with limited evidence of long-term outcomes and predictors of recurrence. Objective: To analyze clinic-radiological features, therapeutic methods, and long-term outcomes in a pediatric cohort. Methods: We retrospectively reviewed patients ≤18 years who underwent surgical resection for spinal ependymomas between January 2012 and July 2024. Progression-free survival (PFS) was estimated using Kaplan-Meier analysis, and predictors of recurrence were analyzed using the Cox proportional hazards method. Results: Among 61 children (age 13.7 ± 3.7 years), spinal ependymoma (EPN) (WHO grade 2) was the most common subtype ( Interpretation: GTR remains the best treatment modality for pediatric patients with spinal ependymomas and has a favorable prognosis. Tumor recurrence is common and is related to the Ki-67 index, histological subtype, and the extent of resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.